Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q2 FY21 results · Jul–Sep 2020
Wockhardt reported revenue from operations of ₹714.05 crore (down 11.0% from Q2 FY20) and net profit of ₹3.29 crore for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 714.05 | 802.18 | −11.0% | 598.27 | +19.4% |
| Other income | 16.24 | (0.20) | Turned profit | 7.95 | +104.3% |
| Total income | 730.29 | 801.98 | −8.9% | 606.22 | +20.5% |
| Profit before tax | (85.11) | (70.55) | Loss widened | (336.24) | Loss narrowed |
| Net profit for the period | 3.29 | (94.24) | Turned profit | 759.75 | −99.6% |
| Attributable to shareholders of the company | 3.55 | (82.17) | Turned profit | 760.06 | −99.5% |
| EPS, basic (₹) | 0.32 | (7.42) | Turned profit | 68.64 | −99.5% |
| Net margin (%) | 0.5 | -11.7 | 127.0 |
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 294.96 | 424.28 | −30.5% | 177.58 | +66.1% |
| Other income | 14.96 | 2.01 | +644.3% | 9.74 | +53.6% |
| Total income | 309.92 | 426.29 | −27.3% | 187.32 | +65.4% |
| Profit before tax | (87.29) | 1.48 | Turned loss | (332.98) | Loss narrowed |
| Net profit for the period | (57.38) | 0.07 | Turned loss | 766.39 | Turned loss |
| EPS, basic (₹) | (5.18) | 0.01 | Turned loss | 69.21 | Turned loss |
| Net margin (%) | -19.5 | 0.0 | 431.6 |
Consolidated
- Filed with BSE
- 03 Nov 2020, 16:13 IST
- Board meeting
- 02 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Nov 2020, 16:13 IST
- Board meeting
- 02 Nov 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE